CoolSculpting

Real Housewife Sonja Morgan Is New Face of CoolSculpting

Real Housewife New Coolsculpting Spokesperson

Television personality Sonja Morgan of Bravo’s “The Real Housewives of New York City” is partnering with CoolSculpting (owned by Allergan) as the face of the brand's latest “Let’s Get Real About Self-Care” campaign. Morgan will share her self-care tips as well as her own personal CoolSculpting story in marketing materials, digital advertising and on CoolSculpting social channels. In addition, she will participate in public relations activities.

CoolSculpting Cleared To Treat Below the Jawline

Noninvasive fat reduction

The U.S. Food and Drug Administration (FDA) had cleared Allergan’s CoolSculpting to treat the submandibular area. In addition, the FDA clearance was expanded to include patients with a BMI of up to 46.2 when treating the submental and submandibular areas.

The efficacy of the CoolSculpting treatment in the area right below the jawline was proven in a 22-week clinical study, which demonstrated an average 33 percent reduction in fat layer thickness after two treatments. Additionally, patient satisfaction with the treatment averaged 85 percent across three studies

Coolsculpting Cleared for Lax Tissue in Conjunction With Submental Fat

Coolsculpting tightens lax skin in double chins

The U.S. Food and Drug Administration (FDA) has cleared Coolsculpting cryolipolysis treatment (Allergan) for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. An 18-week clinical study of Coolsculpting using the CoolMini applicator for the treatment of submental fat found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chins looked more toned following treatment.

Aesthetic Device: Upper Arm Slimming

Main Image: 
Noninvasive fat reduction for arms

The CoolAdvantage Petite applicator from Zeltiq is designed to deliver CoolSculpting cryolipolysis treatments for fat reduction in the upper arms—the most recent indication cleared by the FDA. CoolSculpting gently cools targeted fat cells in the body to induce a controlled elimination of fat without affecting surrounding tissue. The CoolAdvantage Petite applicator includes two interchangeable contours designed to treat the upper arms in 35 minutes. Contact: 925.474.2500, www.coolsculpting.com

No, don't share this with BeautyEtc
Articles: 

CoolSculpting Cleared To Treat Upper Arm Fat

Image of a woman pinching her upper arm fat

The U.S. Food and Drug Administration (FDA) has cleared CoolSculpting (Zeltiq Aesthetics) for the upper arms, adding to its previous clearances for the treatment of fat bulges in the submental area, thigh, abdomen, flank, bra and back fat area, and underneath the buttocks. CoolSculpting is a nonsurgical procedure that selectively reduces unwanted fat using a patented cooling technology. It works by gently cooling targeted fat cells in the body to induce a controlled elimination of fat cells without affecting surrounding tissue.

CoolSculpting FDA Cleared for Submental Fat

CoolSculpting FDA Cleared for Submental Fat

ZELTIQ Aesthetics has received an expanded clearance for submental fat from the U.S. Food and Drug Administration (FDA) in conjunction with the release of its CoolMini applicator—designed to administer CoolSculpting cryolipolysis treatments to smaller pockets of fat, including submental fat. The new applicator’s size, shape and curvature is designed to comfortably fit small, problem areas. Patients may see results as early as three weeks, with the most dramatic results generally observed one to three months following treatment.

CoolSmooth Effective for Treatment of Lateral Thighs

CoolSmooth Effective for Treatment of Lateral Thighs

W. Grant Stevens, MD, FACS, and Eric Bachelor, MD, FACS, investigated the safety and efficacy of the CoolSculpting CoolSmooth applicator from Zeltiq for the cryolipolysis treatment of “nonpinchable” fat in the lateral thighs. A total of 40 patients underwent a 120-minute unilateral treatment with the conformable-surface applicator on one lateral thigh, with the contralateral thigh serving as the control.